Alexion

UK’s AstraZeneca says buying US biotech firm Alexion for $39 billion

• 13-Dec-2020

British pharmaceuticals group AstraZeneca, which is finalising a vaccine against Covid-19, said Saturday it was buying US biotech firm Alexion for $39 billion